This Week: Federal workforce cuts, Trump buyout offer delayed, and FDA’s RTO

This Week at FDAThis Week at FDABiologics/ biosimilars/ vaccinesGovernment/legislationLeadershipMedical DevicesPharmaceuticalsRegulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)